Summary
A summary of a patient's upcoming surgical preparations and current comprehensive medication regimen.
Patient Surgical Planning and Medication Overview
Highlights
Surgical Planning and Assessments
The patient is scheduled for surgery on July 31, 2026. Clinical preparations include a PEG removal procedure, evaluations by physiotherapy and speech therapy, and recent blood tests. Notable blood results indicate elevated Urea (14.8), Creatinine (156), and reduced GFR (51), along with low total protein (59) and Albumin (26), and a hemoglobin level of 11.6.
Medication Regimen
The patient is on an extensive medication list including Afaris, Zolnoxs, Clexane, Navalpro, Redilev, Clonam, Corsodyl, Pyridoxine, Truloc, Bilocor, Carzin XL, Triplixam, Adco-Mirteron, Adco-Ipratropium, and nutritional supplementation via Prosource NoCarb.